ROBO1 and central nervous system cancer: Subsequently, ROBO1 immunohistochemistry, CD31 immunohistochemistry and periodic acid–Schiff (PAS) staining were performed to examine the differences in ROBO1 expression and VM formation among the various grades of glioma tissues and to determine the potential correlation between ROBO1 expression and VM formation.